Tuberculin purified protein derivative (PPD)
Diagnostic agents
Diagnostic agents
A protein extract of tuberculosis bacteria injected into the skin. A firm swelling 2–3 days later suggests infection with the TB germ.
Also called: Mantoux test, tuberculin skin test, PPD
Quick facts
- Group
- Diagnostic agents
- Target
- Memory T cells sensitised to Mycobacterium tuberculosis (delayed, type IV hypersensitivity)
- Used for
- Testing for infection with M · Children under 5
- Key effects
- Itching or discomfort at the site
- Monitor
- Reading of induration · After a positive result
- ATC
- V04CF01
No doses: the clinician sets them by the current guideline.
Mechanism of action
PPD is a standardised mixture of tuberculin proteins. Injected into the skin of someone already infected (or vaccinated with BCG, or exposed to other mycobacteria), memory T cells recognise it and call in other immune cells, which produces a firm, raised area (induration) over two to three days. The response appears only 2–8 weeks after infection. A positive test shows probable infection but does not tell latent infection from active disease.
- PPD is injected into the skin of the forearm
- Memory T cells of a sensitised person recognise it
- Immune cells gather: induration over 48–72 hours
- Induration (not redness) is measured in millimetres
Indications
- Testing for infection with M. tuberculosis, such as in contacts of a person with infectious TB Tuberculosis →
- Screening before immunosuppression, in people with HIV and in health workers (baseline two-step testing)
- Children under 5, in whom the skin test is the recommended test
Adverse effects
Common
- Itching or discomfort at the site
- A firm red swelling in people who test positive
Contraindications
- A previous severe reaction to a tuberculin skin test (necrosis, blistering, ulceration, anaphylaxis)
- Not useful when there is a documented earlier positive test or previous TB treatment
- Pregnancy, infancy and HIV are not contraindications
Key interactions
- Live-virus vaccines (such as measles vaccine)
- Can cause a false-negative result; the test is done the same day as the vaccine or at least one month later
- BCG vaccine
- Earlier BCG can cause a false-positive result
- Immunosuppressants (high-dose corticosteroids, TNF-α antagonists)
- A weakened immune response can make a real infection test negative, so a lower cut-off is used
What is monitored
- Reading of induration (not redness) across the forearm at 48–72 hours
- After a positive result: chest X-ray and sputum tests to look for active TB
Administration and safety
- Given intradermally on the inner forearm with a tuberculin syringe, bevel up (Mantoux technique); a pale wheal should form.
- If no wheal forms or the depth is wrong, the test is repeated at a site well away from the first.
- A test not read within 72 hours is repeated.
Pregnancy and breastfeeding
The skin test is safe in pregnancy and is not contraindicated.
Nursing care
- Make sure the patient can return for the reading in 48–72 hours.
- Measure only the induration in millimetres and record the exact size.
- Ask about earlier BCG, earlier positive tests, recent live vaccines, HIV and immunosuppressive drugs.
- Explain that a negative result does not rule out TB, especially in severe illness or HIV.
Pharmacokinetics
- Onset and duration
- Induration develops over 48–72 hours, the window in which the test is read
Test yourself
Think of the answer, then tap the question to see it.
What is measured in a tuberculin skin test?
The diameter of induration in millimetres at 48–72 hours, not the redness.
What are two causes of a false-positive tuberculin test?
Earlier BCG vaccination and infection with non-tuberculous mycobacteria.
Why can a recent measles vaccine make the tuberculin test unreliable?
Live-virus vaccines can suppress the response and give a false negative.
Does a positive tuberculin test mean active tuberculosis?
No: it shows probable infection; chest X-ray and sputum tests decide whether there is active disease.
Connections
← Back to the class: Diagnostic agents
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Sources: Clinical Testing Guidance for Tuberculosis: Tuberculin Skin Test | Tuberculosis (TB) | CDC (U.S. Centers for Disease Control and Prevention (CDC), 2026); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
